Cantourage
Cantourage · page 2
- Markets & Stocks
Ananda Announces ‘Drug Supply Agreement’, Stenocare Launches 3rd Oil in Denmark, & German Stocks React to CanG Progress
Ananda Developments Ananda Developments has seen its stock increase over 5% this week after signing a ‘Drug Supply Agreement’ (DSA) with the University of Edinburgh (UOE) and NHS Lothian.
- Markets & Stocks
German Cannabis Stocks Spike on CanG Progress, Akanda Offloads Key Sales Generator, & Allied Corp Signs UK Supply Deal
Akanda [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”AKAN” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Akanda has seen its share price slip by around 10% this week after it announced plans to sell its Portuguese operations for $2m, seeing it offload a key source of revenue.
- Markets & Stocks
Cantourage Reports ‘Singificant Revenue Growth’ for 2023, Europe’s Last Cannabis ETF Closes, & SEED Innovations Publishes Interim Results
Cantourage [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HIGH.DE” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Cantourage Group reported its Q3 financial figures this week, celebrating ‘significant revenue growth’ so far in 2023, but slipped back into the red after reporting a positive EBITDA in its interim results in July.
- Press releases
Cantourage Group SE Launches a Range of High-THC Medicinal Cannabis Flowers in Switzerland Together With Astrasana
Cantourage Group SE (hereinafter “Cantourage,” ISIN: DE000A3DSV01, www.cantourage.com), a leading European company for the production and distribution of medical cannabis, has signed a long-term supply agreement for medical cannabis with the Swiss cannabis company Astrasana.
- Markets & Stocks
Cantourage UK Expands Medical Cannabis Access in Gibraltar, SEED Stock Jumps Nearly 30%, & More from Ananda
Cantourage [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HIGH.F” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] This week Cantourage UK, a subsidiary of the German-listed cannabis distribution group, signed a supply agreement which will give residents of Gibraltar greater access to medical cannabis.
- Press releases
Mamedica Launches First Own-Brand Strains of Canadian THC-Dominant Cannabis in the UK With Cantourage
Mamedica® – the UK’s fastest-growing medical cannabis clinic, has partnered with Cantourage UK to launch the first of its own-branded products in the UK.
- Markets & Stocks
German Cannabis Stocks Jump on Passage of Draft Adult-Use Bill, More from Jazz Pharma & Ananda Developments
German Stocks Spike on Passage of Draft Law [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”SBX.DE” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Synbiotic SE (SBX) Yesterday, the German federal cabinet officially passed the draft law which would seek to implement Pillar 1 of the country’s ambitious adult-use cannabis legalisation strategy.
- Markets & Stocks
Cantourage Expects ‘Double Digit’ Sales Increase This Year, Apollon Signs New Licence Agreement, & More from MGC Pharma
Cantourage [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HIGH.F” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] German-listed cannabis distributor Cantourage informed investors this week that it expects to see ‘double digit’ sales growth and ‘a break-even result at EBITDA level’ in 2023.
- Markets & Stocks
Intercure Counter-Sued By Better, Cantourage Sees Stock Jump 30%, & Tikun Olam Cannbit To Be Acquired
Cantourage [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HIGH.F” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] German-listed cannabis distributor has seen its stock price jump by around 30% this week on the Frankfurt stock exchange.
- Markets & Stocks
OCT Secures MHRA Approval For Clinical Trials, Cantourage Posts First Profits, & More From DanCann Pharma
Oxford Cannabinoid Technologies [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”OCTP.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] The London Stock Exchange listed pharmaceutical cannabis company announced yesterday that it has at last secured MHRA approval for its Phase 1 Clinical Trials for its lead compound.
- Markets & Stocks
Cantourage Sees Revenues ‘Almost Triple’, BAT Invests $10m In New CBD Joint Venture, & Love Hemp’s New Owner Targets IPO
Cantourage [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HIGH.F” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] German-based medical cannabis operator Cantourage has seen its stock jump 22% this week after revealing a 95% increase in revenues in its preliminary Q1 results.
